Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion
Author:
Publisher
Mary Ann Liebert Inc
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://www.liebertpub.com/doi/pdf/10.1089/thy.2000.10.587
Reference42 articles.
1. Anaplastic Thyroid Carcinoma: Behavior, Biology, and Therapeutic Approaches
2. Anaplastic giant-cell carcinoma of the thyroid.A study of treatment and prognosis
3. Anaplastic Carcinoma of the Thyroid: A Clinicopathologic Study of 82 Cases
4. Anaplastic Thyroid Carcinoma: Association With Differentiated Thyroid Cancer
Cited by 267 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined radiation and chemotherapy versus monotherapy for anaplastic thyroid cancer: A SEER retrospective analysis;Heliyon;2024-07
2. Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies;Frontiers in Endocrinology;2024-06-26
3. Paclitaxel Inhibits Thyroid Cancer by Regulating AMPK/mTOR and Promoting Ferroptosis;Journal of Biomedical Nanotechnology;2024-06-01
4. The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis;BMC Surgery;2024-03-04
5. Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies;Frontiers in Endocrinology;2024-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3